Agnès Bellanger

1.7k total citations
25 papers, 1.1k citations indexed

About

Agnès Bellanger is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Agnès Bellanger has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pharmacology. Recurrent topics in Agnès Bellanger's work include Glioma Diagnosis and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Brain Metastases and Treatment (3 papers). Agnès Bellanger is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Brain Metastases and Treatment (3 papers). Agnès Bellanger collaborates with scholars based in France, Netherlands and Italy. Agnès Bellanger's co-authors include David Khayat, Estelle Piotto, A. Thuillier, O. Lyon‐Caen, Frédéric Sedel, Damien Galanaud, Jean‐Philippe Collet, Daniel Thomas, Ayman Tourbah and Gilles Montalescot and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Neurology.

In The Last Decade

Agnès Bellanger

25 papers receiving 1.0k citations

Peers

Agnès Bellanger
Renata Zajączkowska Poland
Jennifer S. Gewandter United States
Catherine Y. Lau United States
Karl‐Uwe Petersen Germany
Marek Bolanowski Poland
Jingping Wang China
Jana Zapletalová Czechia
Jin Hyun Kim South Korea
Anders Andersen Norway
Xiaoling Zhang China
Renata Zajączkowska Poland
Agnès Bellanger
Citations per year, relative to Agnès Bellanger Agnès Bellanger (= 1×) peers Renata Zajączkowska

Countries citing papers authored by Agnès Bellanger

Since Specialization
Citations

This map shows the geographic impact of Agnès Bellanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Bellanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Bellanger more than expected).

Fields of papers citing papers by Agnès Bellanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Bellanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Bellanger. The network helps show where Agnès Bellanger may publish in the future.

Co-authorship network of co-authors of Agnès Bellanger

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Bellanger. A scholar is included among the top collaborators of Agnès Bellanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Bellanger. Agnès Bellanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Roos‐Weil, Damien, Nicolas Weiss, Amélie Guihot, et al.. (2021). Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?. Journal of Neurology. 268(7). 2458–2465. 11 indexed citations
3.
Uzunov, Madalina, Sophie Demeret, Véronique Morel, et al.. (2019). Postallogeneic transplantation progressive multifocal leukoencephalopathy successfully treated by nivolumab. British Journal of Haematology. 188(6). e82–e84. 8 indexed citations
4.
Bellanger, Agnès, et al.. (2019). Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate. Journal of Pharmaceutical and Biomedical Analysis. 178. 112896–112896. 4 indexed citations
5.
Kapel, Nathalie, Alexandre Bleibtreu, Agnès Bellanger, et al.. (2018). Faecal microbiota transplantation with frozen capsules for relapsing Clostridium difficile infections: the first experience from 15 consecutive patients in France. Journal of Hospital Infection. 100(2). 148–151. 13 indexed citations
6.
Sedel, Frédéric, Caroline Papeix, Agnès Bellanger, et al.. (2015). High doses of biotin in chronic progressive multiple sclerosis: A pilot study. Multiple Sclerosis and Related Disorders. 4(2). 159–169. 156 indexed citations
7.
Marchetti, Federico, et al.. (2014). Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5‐year study of 51 patients. European Journal of Pain. 19(7). 984–993. 47 indexed citations
8.
Madelaine, Isabelle, Jean‐François Tournamille, Agnès Bellanger, et al.. (2014). Étude impacto : analyse descriptive des pratiques de pharmacie clinique en cancérologie. Annales Pharmaceutiques Françaises. 73(3). 223–228. 8 indexed citations
9.
Lê, Laetitia Minh Maï, et al.. (2012). Effectiveness of cleaning of workplace cytotoxic surface. International Archives of Occupational and Environmental Health. 86(3). 333–341. 31 indexed citations
10.
11.
Debs, Rabab, Christel Depienne, Agnès Rastetter, et al.. (2010). Biotin-Responsive Basal Ganglia Disease in Ethnic Europeans With Novel SLC19A3 Mutations. Archives of Neurology. 67(1). 126–30. 73 indexed citations
12.
Corvol, Jean‐Christophe, Cécilia Bonnet, Fanny Charbonnier‐Beaupel, et al.. (2010). The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial. Annals of Neurology. 69(1). 111–118. 75 indexed citations
13.
Dômont, Julien, Nicolas Magné, Catherine Genestie, et al.. (2010). Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximab. Bulletin du Cancer. 97(2). E9–E15. 4 indexed citations
14.
Caudron, Éric, et al.. (2009). Determination of platinum traces contamination by graphite furnace atomic absorption spectrometry after preconcentration by cloud point extraction. Journal of Hazardous Materials. 176(1-3). 207–212. 25 indexed citations
15.
Taillibert, Sophie, Benjamin Granger, Y. Marie, et al.. (2009). Bevacizumab and irinotecan for recurrent oligodendroglial tumors. Journal of Clinical Oncology. 27(15_suppl). 2054–2054. 6 indexed citations
16.
Aubrun, Frédéric, et al.. (2003). Adjunctive analgesia with intravenous propacetamol does not reduce morphine-related adverse effects. British Journal of Anaesthesia. 90(3). 314–319. 80 indexed citations
17.
Piotto, Estelle, et al.. (2002). Changing patient perceptions of the side effects of cancer chemotherapy. Cancer. 95(1). 155–163. 349 indexed citations
18.
Bellanger, Agnès, et al.. (2001). [Optimization of aerosol therapy in otorhinolaryngology: stability and granulometry of dexamethasone-gomenol-framycetin solution].. PubMed. 118(1). 45–53. 2 indexed citations
19.
Lévy-Piedbois, C, et al.. (2000). Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer. Annals of Oncology. 11(2). 157–161. 35 indexed citations
20.
Fagot, Jean‐Paul, Antoine Flahault, A Kanfer, et al.. (2000). [Prevention of venous thromboembolism in a non-surgical medical ward. Proposed indications for low molecular weight heparin].. PubMed. 29(1). 4–10. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renata Zajączkowska Breakdown of academic impact, for papers by Jennifer S. Gewandter Breakdown of academic impact, for papers by Catherine Y. Lau Breakdown of academic impact, for papers by Karl‐Uwe Petersen Breakdown of academic impact, for papers by Marek Bolanowski Breakdown of academic impact, for papers by Jingping Wang Breakdown of academic impact, for papers by Jana Zapletalová Breakdown of academic impact, for papers by Jin Hyun Kim Breakdown of academic impact, for papers by Anders Andersen Breakdown of academic impact, for papers by Xiaoling Zhang
Rankless by CCL
2026